The Cannabis Connection 2025 will be held on November 6th, in São Paulo, bringing together about 300 participants, including market leaders, experts, and representatives from public and private entities. The meeting, considered one of the most strategic in the cannabis industry in Latin America, will take place in an intimate format, at Av. Juscelino Kubitschek, 1600, focusing on high-level debates and generating relevant connections.

The event takes place at a crucial moment for the sector in Brazil. The National Health Surveillance Agency (Anvisa) is expected to announce in December the updates to RDC 327/2019, a regulation that governs the manufacturing, prescription, and commercialization of cannabis-based products. The public consultation received over 1,500 contributions and discusses advances such as:

- Expansion of administration routes (including sublingual and dermatological);

- Adjustments to prescriptions;

- Possibility of compounding with cannabidiol;

- Flexibility in advertising aimed at prescribing physicians.

Another point of great expectation is the regulation of cannabis cultivation in the country. The federal government has committed to presenting a proposal by the end of September to allow cultivation for medicinal and industrial purposes — a long-awaited topic by the entire production chain.

The event is also expected to address the next steps of RDC 660/2022, which deals with the exceptional importation of products by patients, as well as the appointment of new Anvisa directors. Last Tuesday (19), the Senate Plenary approved the names nominated for the agency's board. For the position of director-president, Leandro Pinheiro Safatle received 54 favorable votes and only two against. The nomination of Thiago Lopes Cardoso Campos was approved with 49 votes in favor and five against. Finally, Daniela Marreco Cerqueira was confirmed with 59 favorable votes and one abstention. The nominees now await official inauguration, still without a defined date.

“More than an event, Cannabis Connection is a space for collective construction, discussing access to medicinal cannabis in Brazil through all possible means. Our goal is to provide information, foster debate, and connect the sector — public, private, and market — to promote health and quality of life for those in need. We also seek to encourage research for the development of therapies for various pathologies, including rare cases, where cannabis has transformed lives. For this, it is essential that regulatory advances, science, and the market move forward together, always focusing on the health and well-being of patients, ensuring a safe regulatory environment for the development of the entire production chain, from cultivation to the product reaching patients’ homes,” say the organizers. 

Confirmed Schedule

November 6, 2025 – São Paulo (SP)

• 2:30 PM – Registration

• 3:00 PM – Sechat Retrospective

• 3:10 PM – Hemp Market Overview

• 3:30 PM – Cannabis in Brazil: Challenges and Perspectives of Post-Regulation Cultivation

• 4:30 PM – Coffee Break

• 5:00 PM – Medicinal Cannabis Market Outlook from 2025 to 2026

• 6:00 PM – Advances for Medicinal Cannabis Regulation in Brazil

• 7:00 PM – Cocktail and Networking

Service

Location: Amphitheater at Av. Juscelino Kubitschek, 1600 – Itaim Bibi – São Paulo – SP
Tickets: available at cannabisconnection.com.br